Rcadia secures four patents for coronary CT decision support

Clint vanSonnenberg | | Health Imaging | Oncology Imaging
Rcadia Medical Imaging has been granted four U.S. patents for the company’s COR Analyzer System.

The U.S. Patent and Trademark Office approved the patents to protect COR Analyzer’s automated algorithmic analysis of coronary CT angiography and for the system’s detection of coronary artery pathology. In addition, the decision support system, which is aimed at emergency department triage of patients with coronary artery disease, gained coverage for its methods of results visualization and automatic assessment of study quality, Auburndale, Mass.-based Rcadia stated.

Clint vanSonnenberg

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.